News | June 30, 2009

Elekta Forms Fund for Cancer Care in Developing Countries

July 1, 2009 - Elekta has formed an investment company, Global Medical Investments "GMI", with Swedfund International AB for financing and establishment of cancer care projects in developing countries.

Global Medical Investments, GMI, will invest, develop and support the establishment of cancer management programs in developing countries across the world in cooperation with local healthcare providers and partners.

Through GMI, Swedfund and Elekta will be able to provide technology and competence for advanced cancer management. Elekta and Swedfund will each invest up to USD 10 M in GMI. Through this initiative Elekta will also strengthen its presence in countries where the company has limited business activities.

GMI is currently in the final stage of development of the first sophisticated radiotherapy center in Accra, Ghana. This is developed in close collaboration with Scandinavian Care Projects AB, which is leading this project, and with local partners. The cancer center is expected to initiate treatment in the first half of 2010, and will give the people in Ghana access to effective and cost efficient cancer treatment with Elekta’s latest technology.

“We believe that this investment, with Swedish expertise in healthcare and medical technology, will contribute to increased availability of advanced medical care. Swedfund participated in the financing of the first GammaKnife in Africa, which is located in Egypt, and we are very pleased by this extended cooperation which we believe will lead to many new cancer centers in developing countries," saids Björn Blomberg, managing director of Swedfund.

For more information: www.swedfund.se and www.elekta.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init